Correlation Between Senti Biosciences and Cadrenal Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Senti Biosciences and Cadrenal Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Senti Biosciences and Cadrenal Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Senti Biosciences and Cadrenal Therapeutics, Common, you can compare the effects of market volatilities on Senti Biosciences and Cadrenal Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Senti Biosciences with a short position of Cadrenal Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Senti Biosciences and Cadrenal Therapeutics,.

Diversification Opportunities for Senti Biosciences and Cadrenal Therapeutics,

-0.71

Correlation Coefficient

Senti Biosciences  Cadrenal Therapeutics,

Pay attention - limited upside

The 3 months correlation between Senti and Cadrenal is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Senti Biosciences and Cadrenal Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cadrenal Therapeutics, and Senti Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Senti Biosciences are associated (or correlated) with Cadrenal Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cadrenal Therapeutics, has no effect on the direction of Senti Biosciences i.e., Senti Biosciences and Cadrenal Therapeutics, go up and down completely randomly.

Pair Corralation between Senti Biosciences and Cadrenal Therapeutics,

Given the investment horizon of 90 days Senti Biosciences is expected to generate 0.5 times more return on investment than Cadrenal Therapeutics,. However, Senti Biosciences is 2.02 times less risky than Cadrenal Therapeutics,. It trades about 0.0 of its potential returns per unit of risk. Cadrenal Therapeutics, Common is currently generating about -0.07 per unit of risk. If you would invest  218.00  in Senti Biosciences on September 2, 2024 and sell it today you would lose (2.00) from holding Senti Biosciences or give up 0.92% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Senti Biosciences  vs.  Cadrenal Therapeutics, Common

Senti Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Senti Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.

Cadrenal Therapeutics,

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Cadrenal Therapeutics, Common are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain forward-looking signals, Cadrenal Therapeutics, exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Senti Biosciences and Cadrenal Therapeutics,

The main advantage of trading using opposite Senti Biosciences and Cadrenal Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Senti Biosciences position performs unexpectedly, Cadrenal Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cadrenal Therapeutics, will offset losses from the drop in Cadrenal Therapeutics,'s long position.

The idea behind Senti Biosciences and Cadrenal Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.